Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt
- PMID: 36583804
- DOI: 10.1007/s10620-022-07806-z
Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt
Abstract
Purpose: To assess and compare the value of psoas muscle thickness at the level of the third lumbar (L3) vertebra (TPML) or umbilicus (TPMU) and skeletal muscle index (SMI) for diagnosing sarcopenia and predicting mortality in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).
Materials and methods: Two hundred forty-nine patients undergoing TIPS were included in this retrospective study. The cut-offs of L3-SMI for sarcopenia were 42.0 cm2/m2 in men and 38.0 cm2/m2 in women. The cut-offs for TPML/height and TPMU/height to predict mortality was established using a receiver-operating characteristic analysis. The Kaplan-Meier and Cox regression were used for survival analyses.
Results: Compared with TPMU/height, TPML/height was more consistent with L3-SM for the diagnosis of sarcopenia (Kappa coefficient: 0.63 vs. 0.36 in men; 0.61 vs. 0.45 in women). The Cox analysis showed that both TPML/height and TPMU/height were independent risk factors for mortality. The optimal cut-off values of TPML/height and TPMU/height for mortality in men and women were 11.2 mm/m, 9.4 mm/m, 18.4 mm/m, 15.1 mm/m, respectively. There were 119 (47.8%), 87 (34.9%), and 82 (32.9%) patients diagnosed with sarcopenia in the TPMU/height, TPML/height, and L3-SMI models, respectively. Kaplan-Meier analysis showed that the overall survival was significantly lower in the sarcopenia group in all three models.
Conclusion: TPMU/height and TPML/height have a similar survival prognostic value as L3-SMI. TPML/height has better consistency with L3-SMI in diagnosing sarcopenia and is a more stable alternative to L3-SMI for diagnosing sarcopenia in patients undergoing TIPS.
Keywords: Mortality; Psoas muscles; Sarcopenia; Skeletal muscle; Transjugular intrahepatic portosystemic shunt.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Comment in
-
Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.Dig Dis Sci. 2023 Apr;68(4):1089-1090. doi: 10.1007/s10620-023-07864-x. Epub 2023 Mar 7. Dig Dis Sci. 2023. PMID: 36881198 No abstract available.
Similar articles
-
Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.Radiology. 2022 Jun;303(3):711-719. doi: 10.1148/radiol.211172. Epub 2022 Mar 15. Radiology. 2022. PMID: 35289658
-
Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.Br J Radiol. 2024 Feb 2;97(1154):331-340. doi: 10.1093/bjr/tqad065. Br J Radiol. 2024. PMID: 38276881
-
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.Clin Transl Gastroenterol. 2019 Apr;10(4):e00025. doi: 10.14309/ctg.0000000000000025. Clin Transl Gastroenterol. 2019. PMID: 30939488 Free PMC article.
-
Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.Am J Gastroenterol. 2020 Nov;115(11):1911-1914. doi: 10.14309/ajg.0000000000000959. Am J Gastroenterol. 2020. PMID: 33156111
-
Impact of Changes in Body Composition after Transjugular Intrahepatic Portosystemic Shunt Creation on Morbidity and Mortality: A Systematic Review.Tech Vasc Interv Radiol. 2025 Sep;28(3):101060. doi: 10.1016/j.tvir.2025.101060. Epub 2025 Jul 9. Tech Vasc Interv Radiol. 2025. PMID: 40784693
Cited by
-
Research status and hotspots in transjugular intrahepatic portosystemic shunts based on CiteSpace bibliometric analysis.World J Gastrointest Surg. 2024 Sep 27;16(9):2996-3007. doi: 10.4240/wjgs.v16.i9.2996. World J Gastrointest Surg. 2024. PMID: 39351573 Free PMC article.
-
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.World J Gastroenterol. 2023 Dec 14;29(46):6028-6048. doi: 10.3748/wjg.v29.i46.6028. World J Gastroenterol. 2023. PMID: 38130738 Free PMC article. Review.
-
Clinical usefulness of psoas muscle thickness for the prognosis of acute type A aortic dissection patients undergoing total arch replacement.J Thorac Dis. 2024 Jun 30;16(6):3722-3731. doi: 10.21037/jtd-24-196. Epub 2024 Jun 25. J Thorac Dis. 2024. PMID: 38983146 Free PMC article.
-
Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients.J Clin Med. 2023 Nov 10;12(22):7029. doi: 10.3390/jcm12227029. J Clin Med. 2023. PMID: 38002642 Free PMC article. Review.
-
Quantitative Assessment of Body Composition in Cirrhosis.Diagnostics (Basel). 2024 Sep 30;14(19):2191. doi: 10.3390/diagnostics14192191. Diagnostics (Basel). 2024. PMID: 39410594 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources